[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CGTX":3,"homepage-market-summary":31,"stock-news-CGTX":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CGTX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Cognition Therapeutics, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).","14","Purchase, NY",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},0.9251,0.921,0.9299,0.9011,0.8912,0.0339,3.8,299681.573005,1220,0.9184,2.05,0.55000001,1084102.636258692,25,1253,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":154},"success",[34,42,49,56,63,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":29,"pct_change":67,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":40,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":40},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},3,[175,181,187],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"An experimental drug slowed the progression of hallucinations and delusions by 89% vs. placebo. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxOM0lyTE9PZlk4UV83b2p5OUtielRQaUpydUJLeTk1eV95ZEh4R0h6ejdoaEtCOWZrSk9kcFE2NXlMZWk5Y0FIYTdZXzgzcTB3LW1ZOHhueWNGYVRodExqWThvejZyWHl6OUktZUdhSEVOUWh3azg1TExIZ3lDdHZKWGdNZHdjTlAzY3pjMDFISVhtY3ZFVTNjNlpBVklmdU9DcWcyaVNSMlUzZmNmZ2hlWmIxSG1VdnlSb21wODFIcw?oc=5","Tue, 29 Sep 2026 11:30:00 GMT","An experimental drug slowed the progression of hallucinations and delusions by 89% vs. placebo. Stock Titan","Stock Titan",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Cognition Therapeutics Schedules FDA Type C Meeting to Discuss Phase 3 Trial Endpoint for Zervimesine in Dementia with Lewy Bodies - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi9gFBVV95cUxONWlINU5aRHEtYUs0NHV3alIzT2xZWWNpTUtuX09FQ29PbGVTLTFxN04zTHJqZFBpdVZaXzRpcEU5NFR3dWNwYlU1cTZLUndZcERNaXE5enB6NFl2dDNoRHpjbndTWTdpTm1KYzJLZW5hV1JUZUthYW0wZm84X3UwbVJUbFhEWE5OamhFZjY0QkxtWjVVM3lCZzRtLXFyWVFoU1cxM3h6T1lfNmZCQnp1bU5SNU9nemtHUHV1MzEzNF91aEUycGRCaC05LXRmQlJreVpmaHJ3VUR1OFlZdXJ4MnBva25OaVV5ajU1UnpPR05jYnVXaGc?oc=5","Tue, 29 Sep 2026 11:42:00 GMT","Cognition Therapeutics Schedules FDA Type C Meeting to Discuss Phase 3 Trial Endpoint for Zervimesine in Dementia with Lewy Bodies Quiver Quantitative","Quiver Quantitative",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"TOYO Stock Crashes More Than 37%, Cracks Below 200-DMA For The First Time In Nearly 13 Months – Retail Calls The Selloff An ‘Overkill’ - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxNTnA3MEJ3MFM4MDZFUlVPeWR1cTlJdlFNV1NoNVlNZEdJbEtCemFHM0lJc0pNTnE0RkpLdG15bGNpVmpTY0xVaExRU0NyckVWTzFqZW9idXN1Z202Wm5CWWdRMFQ3ckNsbzVjYWdseU5qT09QXzVNR29xUDZxb1pJQi1DSUZud1VEVWZLc19FM3lCcXFDN2xxb0ZjbDVzem1fU0xvazZLd1FOQVRHb3dVT1F3?oc=5","Thu, 01 Oct 2026 21:27:17 GMT","TOYO Stock Crashes More Than 37%, Cracks Below 200-DMA For The First Time In Nearly 13 Months – Retail Calls The Selloff An ‘Overkill’ Stocktwits","Stocktwits"]